Global Elastography Imaging Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Elastography Imaging Market Analysis

The elastography imaging market has been expanding rapidly due to its increasing application in the diagnosis of liver diseases, musculoskeletal disorders, and other tissue-related conditions. Elastography, a non-invasive imaging technique used to assess tissue stiffness, is gaining significant traction in medical fields such as radiology, cardiology, and obstetrics/gynecology. This growth is fueled by technological advancements such as Shear Wave Elastography (SWE) and Magnetic Resonance Elastography (MRE), which offer improved precision and faster diagnostic results. Companies such as GE Healthcare, Philips, and Siemens Healthineers have been at the forefront of this innovation, driving advancements in portable and on-platform elastography systems. The market's growth is also supported by the rising demand for non-invasive diagnostic methods, which are less costly and carry fewer risks compared to traditional biopsies. In addition, the growing geriatric population, particularly in regions such as North America and Asia-Pacific, and the increasing prevalence of chronic diseases such as liver fibrosis and musculoskeletal disorders, are contributing to the market’s expansion. As healthcare systems adopt these advanced imaging technologies, the elastography imaging market is expected to continue growing at a robust rate.

Elastography Imaging Market Size

The global elastography imaging market size was valued at USD 5.47 billion in 2024 and is projected to reach USD 11.10 billion by 2032, with a CAGR of 9.23% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Elastography Imaging Market Trends

“Rising Demand for Portable Elastography Systems”

The elastography imaging market is experiencing rapid growth, driven by advancements in diagnostic techniques and an increasing focus on non-invasive testing methods. One notable trend is the rising demand for portable elastography systems, which provide flexibility in various healthcare settings, including outpatient clinics and remote areas. For instance, the development of compact ultrasound devices equipped with elastography capabilities allows for quick, real-time diagnosis of liver diseases and musculoskeletal conditions. This trend is evident in the innovations of companies such as Mindray, which launched the Resona I9 Advanced Technologies ultrasound system with HiFR Sound Touch Elastography to improve diagnostic accuracy and reduce transition times. In addition, the growing use of elastography in assessing tissue stiffness for diseases such as liver fibrosis, non-alcoholic fatty liver disease (NAFLD), and cardiovascular conditions is expanding the market. These technological advancements and the growing need for non-invasive, cost-effective diagnostic tools are driving the elastography imaging market’s continued growth.

Report Scope and Elastography Imaging Market Segmentation        

Elastography Imaging Market Definition

Elastography imaging is a non-invasive diagnostic technique used to measure the stiffness or elasticity of tissues, which can be indicative of underlying diseases or conditions. This method relies on ultrasound, magnetic resonance imaging (MRI), or other imaging technologies to assess tissue stiffness, helping diagnose a variety of medical issues, particularly liver fibrosis, tumors, and musculoskeletal disorders. By analyzing the speed at which a mechanical wave propagates through the tissue, elastography provides crucial information about tissue structure and integrity without the need for biopsies.

Elastography Imaging Market Dynamics

Drivers

• Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases is a major driver for the elastography imaging market. Chronic conditions such as liver fibrosis, cirrhosis, and cancer are on the rise globally, increasing the demand for diagnostic technologies such as elastography that can provide non-invasive, real-time assessment of tissue stiffness. According to the World Health Organization (WHO), liver diseases, including cirrhosis, are among the leading causes of mortality worldwide, with an estimated 1.3 million deaths annually attributed to cirrhosis and liver cancer. For instance, liver fibrosis, which often results from hepatitis C, is a major concern, with approximately 71 million people globally infected with the hepatitis C virus, many of whom are at risk of developing advanced liver fibrosis or cirrhosis. Elastography plays a crucial role in diagnosing these diseases early and monitoring their progression without the need for invasive liver biopsies. This increasing disease burden, coupled with the growing need for efficient and cost-effective diagnostic tools, significantly contributes to the expansion of the elastography imaging market.

• Rising Demand for Early Diagnosis

Rising demand for early diagnosis is a significant driver of the elastography imaging market. Early detection of diseases such as liver fibrosis, liver cancer, and breast cancer is critical for improving patient outcomes, as it allows for timely intervention and better management of these conditions. For instance, the American Cancer Society reports that the 5-year survival rate for liver cancer can be as high as 31% if detected early, compared to only 3% when diagnosed at advanced stages. Similarly, elastography is a non-invasive tool that helps in the early identification of liver fibrosis, which, if left untreated, can progress to cirrhosis or liver cancer. The ability to detect these diseases at an earlier stage through elastography enhances treatment options and reduces overall healthcare costs. As awareness of the benefits of early detection grows, healthcare providers are increasingly adopting elastography technologies for both diagnostic and monitoring purposes, thus fueling the market demand for elastography imaging systems. This shift towards early diagnosis is particularly important as the global incidence of liver and breast cancer continues to rise, further driving the adoption of elastography technologies.

Opportunities

• Increasing Advancements in Elastography Technology

Advancements in elastography technology present a significant market opportunity by enhancing the accuracy, usability, and clinical applications of elastography systems. Recent improvements in software algorithms, such as the development of more precise shear wave elastography techniques, allow for better differentiation between different stages of liver fibrosis, making the technology even more effective in diagnosing liver diseases. Moreover, innovations in elastography hardware, such as portable ultrasound-based devices, have expanded its accessibility in point-of-care settings, enabling faster, more affordable assessments. Integration with other imaging modalities such as MRI further amplifies its diagnostic potential. For Instance, MRI elastography combines the high-resolution capabilities of MRI with elastography, offering a non-invasive, highly accurate method for assessing liver stiffness and detecting tumors in a variety of organs. These technological advancements enhance diagnostic capabilities and drive the growing adoption of elastography across various medical disciplines, including hepatology, oncology, and musculoskeletal imaging. As a result, healthcare providers are increasingly integrating elastography into their practices, creating a significant opportunity for market growth.

• Increasing Awareness and Acceptance of Elastography's Benefits

Increased awareness and acceptance of elastography's benefits is emerging as a key market opportunity, as both healthcare providers and patients become more familiar with its capabilities. Elastography's non-invasive nature and ability to provide real-time, dynamic insights into tissue stiffness make it an attractive alternative to traditional imaging techniques, such as biopsy and CT scans, which are often more invasive and expensive. For instance, in the field of hepatology, elastography is increasingly being used to monitor liver fibrosis in patients with chronic hepatitis C, offering more precise, less painful assessments compared to liver biopsies. The growing recognition of elastography's potential to improve diagnostic accuracy, reduce patient discomfort, and lower healthcare costs is driving its adoption across hospitals, clinics, and diagnostic centers. As patients and clinicians become more aware of its advantages, elastography is gaining popularity as a first-line diagnostic tool, creating a substantial market opportunity for manufacturers and service providers. With its expanding acceptance, elastography is poised to play a pivotal role in the early detection and management of chronic diseases.

Restraints/Challenges

• High Cost of Elastography Systems

One of the major challenges facing the elastography imaging market is the high cost of elastography systems, which can limit their accessibility, particularly in low-resource settings. Advanced technologies such as high-resolution ultrasound and MRI-based elastography systems require significant capital investment, making them costly for many healthcare facilities, especially smaller hospitals or those in developing countries. The expense of purchasing, maintaining, and training staff to use these systems can be a barrier for facilities with limited budgets, resulting in slower adoption and reduced availability. This high cost also hinders the ability of smaller clinics and hospitals to incorporate elastography into their diagnostic services. As a result, while elastography offers valuable diagnostic capabilities, its cost remains a key challenge that can limit widespread adoption, especially in regions where affordable healthcare is a pressing need. Finding ways to reduce the cost of elastography systems or develop more affordable models could present an opportunity to expand its use and drive growth in the market.

• Regulatory and Reimbursement Issues

Regulatory and reimbursement issues represent a significant challenge for the elastography imaging market, as they can impede the widespread adoption of this advanced diagnostic technology. Obtaining regulatory approval for elastography systems can be a time-consuming and expensive process, particularly in regions such as the U.S. and Europe, where strict guidelines must be met before a new medical device can be marketed. For instance, in the U.S., elastography devices must undergo rigorous review by the FDA to ensure their safety and efficacy, which may delay their availability to healthcare providers and patients. In addition, reimbursement for elastography procedures is often limited or inconsistent across different healthcare systems. Many insurers may not fully cover the costs of elastography imaging, particularly in outpatient settings or for non-liver-related indications. This creates financial barriers for healthcare providers, especially smaller clinics or facilities in low-resource areas, making it difficult for them to justify the upfront costs of purchasing and maintaining elastography equipment. Without adequate reimbursement, healthcare providers may be reluctant to adopt elastography imaging, limiting its market penetration and accessibility for patients. As a result, regulatory and reimbursement challenges are key obstacles that hinder the growth of the elastography imaging market, reducing its potential to improve diagnostic outcomes in various medical fields.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Elastography Imaging Market Scope

The market is segmented on the basis of technique, modality, application, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Ultrasound Elastography Imaging
• 1D Transient Elastography
• Point Shear-Wave Elastography
• Shear-Wave Elastography
• Magnetic Resonance Elastography

Modality

• Portable
• On-Platform

Application

• Radiology/General Imaging
• Cardiology
• Obstetrics/Gynecology
• Urology
• Vascular
• Orthopedic and Musculoskeletal
• Others

End Users

• Hospitals
• Clinics
• Diagnostic Laboratories
• Surgical Centers and Diagnostic Centers
• Ambulatory Surgical Centers
• Others

Elastography Imaging Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, technique, modality, application, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the elastography imaging market, primarily driven by the presence of numerous key global players in the healthcare and medical device sectors. This region benefits from significant investments in research and development by manufacturers, who are focused on the commercialization and innovation of elastography systems. Moreover, the rising importance of these imaging technologies among healthcare professionals and end-users, particularly for diagnosing liver diseases and musculoskeletal conditions, contributes to this market growth. The increasing adoption of elastography imaging in clinical settings and the growing demand for non-invasive diagnostic procedures further solidify North America's leading position in this market.

Asia-Pacific is expected to witness significant growth in the elastography imaging market from 2025 to 2032, driven by an expanding geriatric population who are more susceptible to conditions that require diagnostic imaging, such as liver diseases and musculoskeletal disorders. The region's rapid economic development has led to improved healthcare infrastructure and increased investments in medical technologies, further facilitating market expansion. In addition, rising healthcare awareness and enhanced access to better medical services, particularly in emerging economies, are contributing to the growing demand for advanced diagnostic solutions. The combination of these factors positions Asia-Pacific as a key area for growth in the elastography imaging market during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Elastography Imaging Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Elastography Imaging Market Leaders Operating in the Market Are:

• General Electric Company (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• Canon U.S.A., Inc. (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• Hitachi, Ltd. (Japan)
• SAMSUNG (South Korea)
• FUJIFILM Corporation (Japan)
• Esaote SPA (Italy)
• SuperSonic Imagine (France)
• Resoundant, Inc. (U.S.)
• Advanced Instrumentations (U.S.)
• Carestream Health (U.S.)
• Hologic Inc. (U.S.)
• GE HealthCare (U.S.)
• Medtronic (Ireland)
• Shimadzu Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• Shenzhen Landwind Industry Co., Ltd. (China)
• SonoScape Medical Corp (China)

Latest Developments in Elastography Imaging Market

• In November 2023, ZEISS unveiled a new Lattice Structured Illumination Microscopy (SIM) technology, aimed at overcoming the resolution limits of conventional light microscopy, enhancing imaging capabilities for high-resolution imaging applications
• In July 2023, at the Microscopy and Microanalysis (M&M) 2023 Conference, ZEISS Microscopy showcased its latest innovations and introduced interactive display features to highlight new research, offering a glimpse into the future of microscopy technology
• In June 2023, Nikon Instruments Inc. launched the “ECLIPSE Ui” system, a comprehensive microscope-based viewing platform designed for seamless clinical observations, supporting both in-person and remote pathological assessments
• In November 2022, PENTAX Medical introduced its new Performance Endoscopic Ultrasound (EUS) system in Canada, combining the ARIETTA 65 PX ultrasound scanner with the J10 Series Ultrasound Gastroscope, enhancing image quality, enabling real-time tissue elastography, and improving therapeutic access
• In May 2022, Mindray released its Resona I9 Advanced Technologies, incorporating HiFR Sound Touch Elastography, which offers smoother transition times, faster refresh rates, and improved consistency for 2D shear wave imaging
• In March 2022, Fujifilm Healthcare Europe launched the Arietta ultrasound series, including the Arietta 850 DeepInsight and Arietta 650 DeepInsight models, supporting the diagnosis of liver diseases such as hepatitis and cirrhosis by using Real-time Tissue Elastography (RTE) and Shear Wave Measurement (SWM) to color-code and quantify tissue stiffness

SKU-43616